We reappraise the psychiatric potential of calcium channel blockers (CCBs). First, voltage-gated calcium channels are risk genes for several disorders. Second, use of CCBs is associated with altered psychiatric risks and outcomes. Third, research shows there is an opportunity for brain-selective CCBs, which are better suited to psychiatric indications.
Br J Psychiatry
250 - 253
Calcium channels, bipolar affective disorders, novel central nervous system drugs, psychiatry, therapy